Microbial surface carbohydrate structures

Microbial surface carbohydrate structures encompass a diverse array of glycans, polysaccharides, and glycolipids that form the outermost layer of bacteria, fungi, and certain viruses. These structures, including lipopolysaccharides (LPS), peptidoglycan, and capsular polysaccharides, are essential for maintaining microbial structural integrity and protecting against environmental stressors and host immune defenses (NCBI, NBK554414). They serve as critical mediators of adhesion to host tissues and are often the primary Pathogen-Associated Molecular Patterns (PAMPs) recognized by the innate immune system via Pattern Recognition Receptors (PRRs) (PubMed, 26011261). In clinical medicine, these carbohydrates are major targets for glycoconjugate vaccines, which stimulate the production of opsonizing antibodies to prevent invasive infections like pneumonia and meningitis (CDC, Pink Book). Additionally, certain antibiotics like polymyxins and glycopeptides exert their effects by binding to or inhibiting the synthesis of these carbohydrate-rich cell wall components (PubChem, CID 5311003). However, the high degree of structural variability and the potential for molecular mimicry—where microbial glycans resemble host structures—pose significant challenges for therapeutic specificity and safety (PubMed, 12679482).

Other names

Microbial glycansBacterial surface polysaccharidesCell wall carbohydratesCapsular polysaccharidesLipopolysaccharidesTeichoic acidsFungal cell wall glucans

Neutralization of endotoxins, inhibition of cell wall biosynthesis, and induction of antibody-mediated opsonophagocytosis.